Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
QYH Biotech is a Chinese veterinary biologics company focused on the research, development, manufacture, and sale of animal vaccines and diagnostic reagents. The company is particularly active in poultry and livestock vaccines and is designated in China to produce vaccines for major animal diseases including highly pathogenic avian influenza. QYH operates multiple GMP production sites and commercial manufacturing lines, with a broad marketed portfolio spanning live and inactivated veterinary vaccines. Its products are sold domestically and exported to multiple countries in Asia, Africa, and neighboring regions. The company appears to be an established commercial-stage animal health manufacturer rather than a human therapeutics biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on QYH Biotech.